ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
61 841,94
1,56%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Champions Oncology Inc (CSBR)

  7. Champions Oncology Inc (CSBR) Actualités

CSBR

Champions Oncology (CSBR)

Champions Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CSBR
DateHeureSourceTitreSymboleSociété
07/05/202401h46Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CSBRChampions Oncology Inc
13/02/202403h12Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CSBRChampions Oncology Inc
16/01/202417h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CSBRChampions Oncology Inc
13/12/202322h47Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSBRChampions Oncology Inc
12/12/202322h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CSBRChampions Oncology Inc
12/12/202311h50IH Market NewsHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and MoreNASDAQ:CSBRChampions Oncology Inc
28/08/202321h14Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CSBRChampions Oncology Inc
28/08/202321h12Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CSBRChampions Oncology Inc
24/07/202322h17Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CSBRChampions Oncology Inc
05/04/202317h39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CSBRChampions Oncology Inc
21/03/202317h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CSBRChampions Oncology Inc
12/09/202222h53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CSBRChampions Oncology Inc
31/08/202215h29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CSBRChampions Oncology Inc
29/08/202221h17Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)NASDAQ:CSBRChampions Oncology Inc
22/07/202222h29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CSBRChampions Oncology Inc
14/02/202216h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CSBRChampions Oncology Inc
23/07/202119h53Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CSBRChampions Oncology Inc
11/09/202012h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CSBRChampions Oncology Inc
10/12/201822h30PR Newswire (US)Champions Oncology to Announce Second Quarter Financial Results on Monday, December 17, 2018NASDAQ:CSBRChampions Oncology Inc
07/11/201814h30PR Newswire (US)Champions Oncology to Participate in the 9th Annual Craig-Hallum Alpha Select ConferenceNASDAQ:CSBRChampions Oncology Inc
13/09/201822h05PR Newswire (US)Champions Oncology Reports Record Quarterly Revenue of $6.2 MillionNASDAQ:CSBRChampions Oncology Inc
13/09/201814h30PR Newswire (US)Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New YorkNASDAQ:CSBRChampions Oncology Inc
28/08/201814h30PR Newswire (US)Champions Oncology to Announce First Quarter Financial Results on Thursday, September 13, 2018NASDAQ:CSBRChampions Oncology Inc
08/08/201814h30PR Newswire (US)Champions Oncology Granted Full Accreditation by the AAALACNASDAQ:CSBRChampions Oncology Inc
26/07/201822h02PR Newswire (US)Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018NASDAQ:CSBRChampions Oncology Inc
12/07/201814h30PR Newswire (US)Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 26, 2018NASDAQ:CSBRChampions Oncology Inc
18/06/201814h30PR Newswire (US)Champions Oncology Partners with Puma Biotechnology and NSABP Foundation on Metastatic Breast and Colon Cancer Co-clinical PD...NASDAQ:CSBRChampions Oncology Inc
03/05/201814h30PR Newswire (US)Champions Oncology to Present at the 3rd annual Disruptive Growth & Healthcare Conference on May 9thNASDAQ:CSBRChampions Oncology Inc
01/05/201814h30PR Newswire (US)Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology ResearchNASDAQ:CSBRChampions Oncology Inc
04/04/201814h30PR Newswire (US)Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex HouseNASDAQ:CSBRChampions Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CSBR

Dernières Valeurs Consultées

BIT
UC3C8Q
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés